An estimated 21.5% of patients in the United States who have had COVID-19 report development of a prolonged postviral syndrome that has been called postacute sequelae of COVID-19 (PASC). Symptoms can range from very mild to debilitating damage to organ systems caused directly by the virus and indirectly by the body’s inflammatory response. Research into defining PASC and discovering effective treatments is ongoing. This activity discusses the common presentations of PASC in patients who have had COVID-19; describes specific effects on the pulmonary, cardiovascular, and central nervous systems; and identifies potential treatments based on current literature.

Learning Objectives

• Recognize the common symptoms associated with PASC
• Understand the potential long-term effects of COVID-19 on the pulmonary, cardiovascular, and central nervous systems
• Identify recommended treatment options for PASC as defined by current literature

---

Managing Patients With Sex-, Race-, or Ethnicity-Based Cardiovascular Health Inequities

Learning Objectives

• Identify differences in diagnosis and treatment of CVD among cisgender women compared with cisgender men
• Recognize cardiovascular risk factors among transgender and gender-diverse patients
• Recognize the occurrence and prevention of racial differences in outcomes of CVD
• Develop awareness of the relationships among depression, anxiety, and ACS